Johnson FM - Search Results

1

Revisiting Feeding Tube Utilization in Oropharynx Cancer: 6-Year Prospective Registry Analysis.

Anderson BJ, Moreno AC, Qing Y, Lee JJ, Johnson FM, Lango MN, Barbon CEA, Tripuraneni L, Sahli A, Piper V, Gross N, Fuller CD, Lai SY, Myers JN, Hutcheson KA. Anderson BJ, et al. Among authors: johnson fm. Otolaryngol Head Neck Surg. 2024 May;170(5):1319-1330. doi: 10.1002/ohn.672. Epub 2024 Feb 14. Otolaryngol Head Neck Surg. 2024. PMID: 38353360 Free PMC article.

2

Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancer.

Johnson FM, Kurie JM, Peeples BO, Lee JJ, Feng L, Pisters KM, Fossella FV, Papadimitrakopoulou VA, Blumenschein GR, Komaki R, Glisson BS. Johnson FM, et al. Clin Lung Cancer. 2003 Jul;5(1):40-5. doi: 10.3816/CLC.2003.n.020. Clin Lung Cancer. 2003. PMID: 14596703 Clinical Trial.

3

Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion.

Tsao AS, He D, Saigal B, Liu S, Lee JJ, Bakkannagari S, Ordonez NG, Hong WK, Wistuba I, Johnson FM. Tsao AS, et al. Among authors: johnson fm. Mol Cancer Ther. 2007 Jul;6(7):1962-72. doi: 10.1158/1535-7163.MCT-07-0052. Mol Cancer Ther. 2007. PMID: 17620427

4

Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches.

Lai SY, Johnson FM. Lai SY, et al. Among authors: johnson fm. Drug Resist Updat. 2010 Jun;13(3):67-78. doi: 10.1016/j.drup.2010.04.001. Epub 2010 May 14. Drug Resist Updat. 2010. PMID: 20471303 Review.

5

Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer.

Taoudi Benchekroun M, Saintigny P, Thomas SM, El-Naggar AK, Papadimitrakopoulou V, Ren H, Lang W, Fan YH, Huang J, Feng L, Lee JJ, Kim ES, Hong WK, Johnson FM, Grandis JR, Mao L. Taoudi Benchekroun M, et al. Among authors: johnson fm. Cancer Prev Res (Phila). 2010 Jul;3(7):800-9. doi: 10.1158/1940-6207.CAPR-09-0163. Epub 2010 Jun 22. Cancer Prev Res (Phila). 2010. PMID: 20570883 Free PMC article. Clinical Trial.

6

STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma.

Sen B, Peng S, Woods DM, Wistuba I, Bell D, El-Naggar AK, Lai SY, Johnson FM. Sen B, et al. Among authors: johnson fm. Clin Cancer Res. 2012 Jan 1;18(1):127-39. doi: 10.1158/1078-0432.CCR-11-1889. Epub 2011 Nov 16. Clin Cancer Res. 2012. PMID: 22090359 Free PMC article.

7

Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: Association with locoregional recurrence, distant metastasis, and decreased survival.

Sandulache VC, Ow TJ, Daram SP, Hamilton J, Skinner H, Bell D, Rosenthal DI, Beadle BM, Ang KK, Kies MS, Johnson FM, El-Naggar AK, Myers JN. Sandulache VC, et al. Among authors: johnson fm. Head Neck. 2013 Oct;35(10):1454-60. doi: 10.1002/hed.23173. Epub 2012 Sep 28. Head Neck. 2013. PMID: 23018868

8

Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancers.

Peng S, Creighton CJ, Zhang Y, Sen B, Mazumdar T, Myers JN, Lai SY, Woolfson A, Lorenzi MV, Bell D, Williams MD, Johnson FM. Peng S, et al. Among authors: johnson fm. J Transl Med. 2013 Aug 27;11:198. doi: 10.1186/1479-5876-11-198. J Transl Med. 2013. PMID: 23981300 Free PMC article.

9

A phase I/II study combining erlotinib and dasatinib for non-small cell lung cancer.

Gold KA, Lee JJ, Harun N, Tang X, Price J, Kawedia JD, Tran HT, Erasmus JJ, Blumenschein GR, William WN, Wistuba II, Johnson FM. Gold KA, et al. Among authors: johnson fm. Oncologist. 2014 Oct;19(10):1040-1. doi: 10.1634/theoncologist.2014-0228. Epub 2014 Aug 28. Oncologist. 2014. PMID: 25170013 Free PMC article. Clinical Trial.

10

A comprehensive evaluation of biomarkers predictive of response to PI3K inhibitors and of resistance mechanisms in head and neck squamous cell carcinoma.

Mazumdar T, Byers LA, Ng PK, Mills GB, Peng S, Diao L, Fan YH, Stemke-Hale K, Heymach JV, Myers JN, Glisson BS, Johnson FM. Mazumdar T, et al. Among authors: johnson fm. Mol Cancer Ther. 2014 Nov;13(11):2738-50. doi: 10.1158/1535-7163.MCT-13-1090. Epub 2014 Sep 5. Mol Cancer Ther. 2014. PMID: 25193510 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters